15.8
遺伝子の機能を知るためには、遺伝子を不活性化したり、ノックアウトしたりすることで、何が起こるかを観察できます。ノックアウトマウスは、がん、パーキンソン病、糖尿病などのヒトの病気のモデルとして特に有用です。
遺伝子をランダムにノックアウトする方法と、特定の遺伝子をターゲットにする方法がありま…
科学者は動物の遺伝子を 無効化またはノックアウトすることができます 典型的にネズミを用いて、遺伝子の機能を研究します 通常、人工的なDNAの一端であるターゲティングベクターと 入れ替えることによって行います ターゲティングベクターは、遺伝子の前後の配列と 相当かつ同一の配列を持っています それはまた、陽性選択マーカーを持っており ネオマイシン抵抗遺伝子や 中間にNeoRを持っています。陰性選択マーカーとして チミジンキナーゼ遺伝子、TKが末尾に付きます 胚性幹細胞に導入される際 相同組み替えと通じて遺伝子を置換し 配列が類似するDNAの一部との間で 自然に行われます 遺伝子が正常に置換された細胞は 陽性マーカーを含みますが、陰性マーカーは含みません こうして、性質によって特定が可能になります これらの細胞は、ネズミの胚に挿入され メスの子宮内に移植されます その結果、ネズミは通常の細胞と 1つの染色体がノックアウトされた遺伝子を持つ細胞を持ちます これらのネズミは、飼育され 通称ノックアウトマウスを生成します 全細胞内に同型接合的なノックアウトが見られます
View the full transcript and gain access to JoVE Core videos
Q1: What is a targeting vector and how does it work in gene knockout?
A targeting vector is an engineered piece of DNA designed to replace a specific gene through homologous recombination. It contains sequences identical to the DNA flanking the target gene, allowing it to recognize and replace the correct location. The vector also includes a positive selection marker like neomycin resistance and a negative selection marker like thymidine kinase to identify successful replacements in embryonic stem cells.
Q2: How does homologous recombination enable gene replacement in knockout mice?
Homologous recombination is a natural process where DNA sequences with identical or homologous regions exchange genetic material. When a targeting vector containing homologous sequences is introduced into embryonic stem cells, the cell's machinery recognizes the matching sequences and replaces the target gene with the vector. This precise mechanism ensures the correct gene is inactivated rather than random DNA insertion.
Q3: Why are selection markers used in targeting vectors?
Selection markers identify cells where the targeting vector has successfully replaced the gene. The positive marker, such as neomycin resistance, allows only cells containing the vector to survive antibiotic exposure. The negative marker, like thymidine kinase, is present only in cells with random vector insertion, enabling researchers to eliminate these unwanted cells using ganciclovir and isolate correctly targeted cells.
Q4: What is a chimera mouse and why is it an intermediate step?
A chimera mouse is composed of a mixture of cells—some with normal DNA and some with the knocked-out gene on one chromosome. It results from inserting engineered embryonic stem cells into a mouse embryo. Chimera mice are intermediate because they are heterozygous for the knockout; they must be bred with each other to produce offspring where every cell is homozygous for the knockout.
Q5: How are knockout mice generated from chimera mice?
Chimera mice are bred together, and offspring carrying the knockout gene in their germline are selected. These mice are further crossbred to create a line where every cell is homozygous for the knockout, meaning both copies of the gene are inactivated. This multi-generational breeding process ensures consistent knockout expression across all tissues for reliable research studies.
Q6: What are common applications of knockout mice in disease research?
Knockout mice serve as valuable models for understanding human diseases by observing what happens when specific genes are inactivated. They have been particularly useful for studying cancer, Parkinson's disease, and diabetes. By comparing knockout mice to normal mice, researchers can determine how the absent gene contributes to disease development and progression.
Q7: How is the targeting vector introduced into embryonic stem cells?
The targeting vector is introduced into mouse embryonic stem cells using electroporation, a technique that applies electric pulses to temporarily create pores in the cell membrane. This allows the engineered DNA to enter the cells where homologous recombination can occur. Once inside, cells with successful gene replacement are identified using selection markers and then inserted into mouse embryos for development.